DE69514532D1 - Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung - Google Patents

Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung

Info

Publication number: DE69514532D1
Authority: DE; Germany
Prior art keywords: pct; date; indol; dione; production
Prior art date: 1994-09-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69514532T

Other languages

English (en)

Other versions

DE69514532T2 (de

Inventor

Peter Moldt

Frank Waetjen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

NTG Nordic Transport Group AS

Original Assignee

Neurosearch AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-14

Filing date

1995-09-12

Publication date

2000-02-17

1995-09-12 Application filed by Neurosearch AS filed Critical Neurosearch AS

2000-02-17 Publication of DE69514532D1 publication Critical patent/DE69514532D1/de

2000-07-06 Application granted granted Critical

2000-07-06 Publication of DE69514532T2 publication Critical patent/DE69514532T2/de

2015-09-13 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DE69514532T 1994-09-14 1995-09-12 Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung Expired - Lifetime DE69514532T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK105394		1994-09-14
PCT/EP1995/003593 WO1996008494A1 (en)	1994-09-14	1995-09-12	Indole-2,3-dione-3-oxime derivatives, their preparation and use

Publications (2)

Publication Number	Publication Date
DE69514532D1 true DE69514532D1 (de)	2000-02-17
DE69514532T2 DE69514532T2 (de)	2000-07-06

Family

ID=8100455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69514532T Expired - Lifetime DE69514532T2 (de)	1994-09-14	1995-09-12	Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung

Country Status (12)

Country	Link
US (1)	US5917053A (de)
EP (1)	EP0781284B1 (de)
JP (1)	JP3164371B2 (de)
AT (1)	ATE188700T1 (de)
AU (1)	AU687255B2 (de)
CA (1)	CA2199613C (de)
DE (1)	DE69514532T2 (de)
EE (1)	EE03355B1 (de)
FI (1)	FI112482B (de)
NO (1)	NO308852B1 (de)
NZ (1)	NZ293265A (de)
WO (1)	WO1996008494A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA54403C2 (uk) *	1996-10-01	2003-03-17	Н'Юросерч А/С	Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
DE69922936T2 (de) *	1998-03-31	2005-12-08	Neurosearch A/S	Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
CA2369746A1 (en)	1999-05-19	2000-11-30	Neurosearch A/S	Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
AU781067B2 (en)	2000-01-24	2005-05-05	Neurosearch A/S	Isatine derivatives with neurotrophic activity
WO2002064139A1 (en) *	2001-02-15	2002-08-22	Neurosearch A/S	Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
BR0211140A (pt)	2001-07-13	2005-10-25	Upjohn Co	Compostos e composições de indóis de hexaidroazepina (4, 5-g) e indolinas como ligantes de receptores 5-ht
US7718641B2 (en)	2005-11-23	2010-05-18	Aros Pharma Aps	Pyrrolo [3,4-H] isoquinoline compounds and methods for modulating gated ion channels
WO2008031831A2 (en) *	2006-09-12	2008-03-20	Neurosearch A/S	Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE69677B1 (en) *	1989-12-11	1996-10-02	Neurosearch As	Isatine derivatives their preparation and use
CA2076948C (en) *	1991-08-28	2002-04-16	Frank Watjen	Isatineoxime derivatives, their preparation and use
AU680632B2 (en) *	1992-10-13	1997-08-07	Neurosearch A/S	Quinoxalinedione derivatives as EAA antagonists

1995
- 1995-09-12 NZ NZ293265A patent/NZ293265A/en unknown
- 1995-09-12 CA CA002199613A patent/CA2199613C/en not_active Expired - Fee Related
- 1995-09-12 EP EP95932729A patent/EP0781284B1/de not_active Expired - Lifetime
- 1995-09-12 JP JP50990796A patent/JP3164371B2/ja not_active Expired - Fee Related
- 1995-09-12 WO PCT/EP1995/003593 patent/WO1996008494A1/en active IP Right Grant
- 1995-09-12 US US08/809,082 patent/US5917053A/en not_active Expired - Lifetime
- 1995-09-12 DE DE69514532T patent/DE69514532T2/de not_active Expired - Lifetime
- 1995-09-12 AU AU35664/95A patent/AU687255B2/en not_active Ceased
- 1995-09-12 AT AT95932729T patent/ATE188700T1/de not_active IP Right Cessation
- 1995-09-12 EE EE9700052A patent/EE03355B1/xx not_active IP Right Cessation
1997
- 1997-02-21 FI FI970750A patent/FI112482B/fi active
- 1997-02-27 NO NO970904A patent/NO308852B1/no unknown

Also Published As

Publication number	Publication date
WO1996008494A1 (en)	1996-03-21
FI970750A0 (fi)	1997-02-21
FI112482B (fi)	2003-12-15
NZ293265A (en)	1998-01-26
FI970750L (fi)	1997-03-13
NO970904L (no)	1997-04-24
CA2199613A1 (en)	1996-03-21
AU687255B2 (en)	1998-02-19
EP0781284A1 (de)	1997-07-02
NO970904D0 (no)	1997-02-27
JPH09511524A (ja)	1997-11-18
CA2199613C (en)	2000-02-29
ATE188700T1 (de)	2000-01-15
US5917053A (en)	1999-06-29
NO308852B1 (no)	2000-11-06
AU3566495A (en)	1996-03-29
EP0781284B1 (de)	2000-01-12
EE03355B1 (et)	2001-02-15
DE69514532T2 (de)	2000-07-06
JP3164371B2 (ja)	2001-05-08

Publication	Publication Date	Title
DE3576331D1 (de)	1990-04-12	Tetralin-derivate, ihre herstellung und verwendung.
ATE45942T1 (de)	1989-09-15	Diarylacetylene, ihre herstellung und verwendung.
ATE108774T1 (de)	1994-08-15	Isoindolonderivate, ihre herstellung und ihre verwendung als zwischenprodukte zur herstellung von substanz-p-antagonisten.
DE69912618D1 (de)	2003-12-11	NEUE THIENO[2,3-d]PYRIMIDINDIONE, VERFAHREN FÜR IHRE HERSTELLUNG UND IHRE VERWENDUNG IN DER THERAPIE
ES2105617T3 (es)	1997-10-16	Derivados de piperacina como antagonistas de 5-ht.
DK0587088T3 (da)	1996-09-23	Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
DE3578063D1 (de)	1990-07-12	1-substituierte tetralinderivate, ihre herstellung und verwendung.
ATE161259T1 (de)	1998-01-15	Ampa antagonisten und behandlungsmethode
ATE201671T1 (de)	2001-06-15	Chinolon und acridinon derivate zur behandlung der harninkontinenz
DE69514532D1 (de)	2000-02-17	Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung
ATE85334T1 (de)	1993-02-15	Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung.
DE69102762D1 (de)	1994-08-11	Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
ATE193705T1 (de)	2000-06-15	4-p-fluorbenzoyl-1-piperidinyl-propoxy-chromen- - on derivate, deren herstellung und deren verwendung zur behandlung von psychosen und schizophrenie
ES8604843A1 (es)	1986-03-01	Un metodo para la preparacion de un derivado de acetileno
DE59209437D1 (de)	1998-09-03	Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung
DE59209494D1 (de)	1998-10-15	Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung
ATE218138T1 (de)	2002-06-15	N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ATE195072T1 (de)	2000-08-15	Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
ATE212842T1 (de)	2002-02-15	Quinoxalin-derivate zur behandlung von tinnitus
PL311296A1 (en)	1996-02-05	Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents
ATE124398T1 (de)	1995-07-15	1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.
DK0461012T3 (da)	1994-09-12	Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse
ATE155479T1 (de)	1997-08-15	Neue cytarabin-derivate, ihre herstellung und verwendung

Legal Events

Date	Code	Title	Description
2001-02-01	8364	No opposition during term of opposition